ZimVie Stock (NASDAQ:ZIMV)


ForecastOwnershipChart

Previous Close

$18.99

52W Range

$8.15 - $19.01

50D Avg

$18.91

200D Avg

$13.49

Market Cap

$535.63M

Avg Vol (3M)

$723.84K

Beta

2.06

Div Yield

-

ZIMV Company Profile


ZimVie Inc. operates as a medical technology enterprise, specializing in the design, manufacturing, and global distribution of an extensive array of products and solutions. These offerings are engineered to address various spinal conditions and facilitate dental tooth replacement and restorative procedures. Its comprehensive dental portfolio encompasses implant systems, along with associated prosthetic and abutment components, and the necessary surgical instrumentation and kits. The company also supplies advanced regenerative products such as bone grafts, barrier membranes, allografts, and collagen-based wound care solutions. Furthermore, it provides cutting-edge digital dentistry tools, including intraoral scanners, virtual treatment planning services, guided surgery capabilities, CAD/CAM workflow systems, and customized restorative parts. In the spinal segment, ZimVie offers a range of fusion implants and specialized instrumentation for diverse surgical interventions, including biologics and innovative bone healing technologies. Notably, its specialized spinal offerings include minimally invasive surgery (MIS) solutions, exemplified by products like Vital MIS and Timberline, as well as advanced motion preservation technologies such as Mobi-C and The Tether. Established in 2021, ZimVie Inc. maintains its corporate headquarters in Westminster, Colorado.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

1,770

IPO Date

Feb 16, 2022

Website

ZIMV Performance


Latest Earnings Call Transcripts


Q1 25May 08, 25 | 4:30 PM
Q4 24Feb 26, 25 | 4:30 PM
Q3 24Oct 30, 24 | 4:30 PM

Peer Comparison


TickerCompany
SPRYARS Pharmaceuticals, Inc.
IVVDInvivyd, Inc.